Status:
COMPLETED
Alcohol, Inflammation and Atherosclerosis
Lead Sponsor:
European Research Advisory Board
Conditions:
Arteriosclerosis
Myocardial Infarction
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Effect of moderate alcohol consumption in form of red wine, beer and ethanol solution and corresponding de-alcoholised beverages on immune measures. * In healthy middle aged men and women * In a rand...
Detailed Description
Alcohol consumption and mortality from all causes are associated in a U-shaped manner. That means that individuals who regularly consume moderate amounts of alcohol (\~1 to 2 drinks/day at maximum) on...
Eligibility Criteria
Inclusion
- 20-60 years
- non-smoker
- healthy
Exclusion
- personal or family history of dependency
- any chronic disease
- acute and chronic inflammatory processes
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00764426
Start Date
June 1 2004
Last Update
October 2 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ulm, Medical Center
Ulm, Germany, 89081